$ANNX News

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Annexon Eyes ‘Win Season’ With Q4 Vision Trial Data, GBS Filings Ahead

Annexon, Inc. (ANNX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Annexon Maps 3 Big Pipeline Catalysts Ahead of Q4 Vision-Drug Readout

Annexon to Participate in Upcoming June Investor Conferences

Annexon Highlights Q4 Geographic Atrophy Data, GBS Filing Plans at BofA Conference

Annexon, Inc. (ANNX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Goldman Sachs Initiates Coverage On Annexon with Neutral Rating, Announces Price Target of $7

Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones

Annexon Q1 EPS $(0.23) Beats $(0.29) Estimate

Annexon to Present at the Bank of America Securities Health Care Conference 2026

Annexon (ANNX): 7 Small Cap Stocks with the Highest Upside Potential

Annexon Biosciences (ANNX) Buy Rating Retained

Annexon CEO Touts “Win Year” 2026 at Needham, Eyes GA Phase III Data and GBS FDA Filing

Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference

Wall Street Analysts See a 165.52% Upside in Annexon (ANNX): Can the Stock Really Move This High?

Is Annexon (NASDAQ:ANNX) In A Good Position To Deliver On Growth Plans?

Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones

Annexon Q4 EPS $(0.28) Beats $(0.32) Estimate

Annexon, Inc. (ANNX) Discusses Vision Preservation in Geographic Atrophy With C1q Inhibition and Key Insights From ARCHER Trials - Slideshow